| Lot Release Number |
2021-03-03-0101
|
| FDA Registered Product/Generic Name |
Omalizumab
|
| Brand Name |
XOLAIR
|
| Dosage Strength |
202.5 mg (150mg/ 1.2mL Reconstituted solution)
|
| Dosage Form |
Lyophilized powder for injection
|
| Registration Number |
BR-987
|
| Batch/Lot Number |
STF48 (bulk batch)
|
| Packaging Lot |
Packaging Lot (Box & Vial): SAHE8; Diluent: 11580832
|
| Product Expiration Date |
30 September 2023
|
| Issuance Date |
05 March 2021
|